Contract A207_PO-0026005-V3

The University of Virginia awarded contract A207_PO-0026005-V3 to Eurofins Genomics LLC on September 26, 2026, with a total cumulative value of nine dollars. The contract is for the procurement of synthetic oligonucleotide products, specifically two distinct DNA sequences designated as M13 Forward and M13 Reverse variants. Both line items are salt-free, 25-base pair oligonucleotides commonly used in molecular biology applications. The contract specifies a quantity of four units each for both the M13 FWD-CCTTTAGTGGTACCTTTCTAT sequence and the M13 REV-GCCCTCATAGTTAGCGTAACG sequence, with delivery directed to the contracting organization.

Eurofins Genomics LLC, the prime contractor, is responsible for manufacturing and delivering these oligonucleotide products to the University of Virginia in Virginia. The line items indicate a unit price of one dollar per oligonucleotide sequence, resulting in the stated cumulative contract value of nine dollars. The contract award documentation does not specify a defined performance period beyond the award date, nor does it delineate an annual value separate from the cumulative contract amount.